Intracellular T cell cytokines in patients with B cell chronic lymphocytic leukaemia (B-CLL)

European Journal of Haematology

Volumn 68, Issue 5, 2002, Pages 299-306

  Rossmann, Eva D ^a   Lewin, Nongnit ^a   Jeddi Tehrani, Mahmood ^a,b   Österborg, Anders ^a   Mellstedt, Håkan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Avesina Research Center   (Iran)

Author keywords

B CLL; Cytokines; Growth factors; Paracrine production; T cells

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CELL FUNCTION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; PATHOGENESIS; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036348617     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2002.01612.x     Document Type: Article

References (32)

1. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukaemia: Revised guidelines for diagnosis and treatment
2. Biology of the neoplastic lymphocyte in B-CLL
3. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease
4. T-cell function in chronic lymphocytic leukaemia
5. Impaired T-cell responses in chronic lymphocytic leukaemia: Lack of suppressor cell effect
6. Immunoregulation of B lymphocyte colony formation by T cell subsets in patients with chronic lymphocytic leukaemia
7. Abnormal T cell function in early-stage chronic lymphocytic leukaemia (CLL) patients
8. Abnormal T-cell subpopulation function in CLL: Excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferation
9. Expression and regulation of tumour necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukaemia
10. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies
11. Interleukin-4 inhibits both paracrine and autocrine tumour necrosis factor-alpha-induced proliferation of B chronic lymphocytic leukaemia cells
12. Antiproliferative effect of interleukin-4 in B chronic lymphocytic leukaemia
13. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukaemia
14. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro
15. Effect of anti-APO1 on spontaneous apoptosis of B cells in chronic lymphocytic leukaemia: The role of bcl-2 and interleukin 4
16. Cytokine induction of leucocyte adhesion molecule-1 (LAM-1) expression on chronic lymphocytic leukaemia cells
17. Autologous T lymphocytes may specifically recognise leukaemic B cells in patients with chronic lymphocytic leukaemia
18. + cells from B chronic lymphocytic leukaemia patients
19. Cytoplasmic interleukin-4 (IL-4) and surface IL-4 receptor expression in patients with B-cell lymphocytic leukaemia
20. Analysis of blood T-cell cytokine expression in B-chronic lymphocytic leukaemia: Evidence for increased levels of cytoplasmic IL-4 in resting and activated CD8 T cells
21. Reduced IL-4 and interferon-gamma (IFN-gamma) expression by CD4 T cells in patients with chronic lymphocytic leukaemia
22. Treatment of chronic lymphocytic leukaemia and well differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone
23. EBV infection of B-CLL cells in vitro potentiates their allostimulatory capacity if accompanied by acquisition of the activated phenotype
24. Detection of intracellular cytokines by flow cytometry
25. Morphological variants of leukaemic cells in B chronic lymphocytic leukaemia are associated with different T cell and NK cell abnormalities
26. Interleukin 4-producing CD4 T cells arise from different precursors depending on the conditions of antigen exposure in vivo
27. The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
28. T helper 2-dominant antilymphoma immune response is associated with fatal outcome
29. Granuloctye-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes
30. Tomuour necrosis factor in B chronic lymphocytic leukemia
31. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidnece for multiple in vivo T cell clonal expansions
32. T cell clonal anergy